493-MV) binds with an ED₅₀ of 0.015-0.12 μg/mL." class="big_lightbox"> 493-MV) binds with an ED₅₀ of 0.015-0.12 μg/mL." alt="When Recombinant Mouse VEGFR2/KDR/Flk-1 (Catalog # 10095-KD) is immobilized at 0.5 μg/mL, 100 μL/well, Recombinant Mouse VEGF 164 (Catalog # 493-MV) binds with an ED₅₀ of 0.015-0.12 μg/mL." class="big_thumb" />

293-VE) dependent proliferation of HUVEC human umbilical vein endothelial cells. The ED₅₀ for this effect is 0.350-3.50 μg/mL." class="big_lightbox"> 293-VE) dependent proliferation of HUVEC human umbilical vein endothelial cells. The ED₅₀ for this effect is 0.350-3.50 μg/mL." alt="Recombinant Human VEGFR2/KDR/Flk-1 His-tag Protein (Catalog # 10964-KD) inhibits the Recombinant Human VEGF₁₆₅ (293-VE) dependent proliferation of HUVEC human umbilical vein endothelial cells. The ED₅₀ for this effect is 0.350-3.50 μg/mL." class="big_thumb" />

293-VE) is immobilized at 1 μg/mL (100 μL/well), Biotinylated Recombinant Human VEGFR2/KDR/Flk-1 Fc Chimera Avi-tag (AVI10460) binds with an ED50 of 4-40 ng/mL." class="big_lightbox"> 293-VE) is immobilized at 1 μg/mL (100 μL/well), Biotinylated Recombinant Human VEGFR2/KDR/Flk-1 Fc Chimera Avi-tag (AVI10460) binds with an ED50 of 4-40 ng/mL." alt="When Recombinant Human VEGF 165 (293-VE) is immobilized at 1 μg/mL (100 μL/well), Biotinylated Recombinant Human VEGFR2/KDR/Flk-1 Fc Chimera Avi-tag (AVI10460) binds with an ED50 of 4-40 ng/mL." class="big_thumb" />

AVI10460) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 145-165 kDa and 290-330 kDa, respectively." class="big_lightbox"> AVI10460) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 145-165 kDa and 290-330 kDa, respectively." class="big_thumb" />